Adverse events during testosterone replacement therapy in 95 young hypogonadal thalassemic men

BACKGROUND: Hormonal treatment of hypogonadism in thalassaemia major (TM) is a complex issue due to the co-existence of other contributing factors such as severity of iron overload, associated chronic liver disease and other endocrine complications. OBJECTIVES: Data about adverse events (AEs) of tes...

Descripción completa

Detalles Bibliográficos
Autores principales: Vincenzo, De Sanctis, Ashraf, T Soliman, Shahina, Daar, Salvatore, Di Maio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mattioli 1885 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6776204/
https://www.ncbi.nlm.nih.gov/pubmed/31125000
http://dx.doi.org/10.23750/abm.v90i2.8477

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6776204/
https://www.ncbi.nlm.nih.gov/pubmed/31125000
http://dx.doi.org/10.23750/abm.v90i2.8477

Ejemplares similares